Four Republican Senators Say They Oppose Obamacare Replacement Plan

In a March 6 letter to Sen. Majority Leader Mitch McConnell, R-Kent., four GOP senators said they oppose a Feb. 10 Obamacare "Repeal and Replace" plan that has been circulating around Congress because it does not provide stability or certainty for individuals in Medicaid expansion programs. A device tax repeal is included in the plan.

Four Republican senators sent a letter to Senate Majority Leader Mitch McConnell March 6 saying they do not support a recent Affordable Care Act "repeal and replacement" plan that is being circulated in the US Congress due to concerns about funding and coverage for Medicaid expansion. A copy of the letter to McConnell is available on Sen. Cory Gardner's, R-Colo., website.

Gardner, Rob Portman, R-Ohio, Shelley Moore Capito, R-W.Va., and Lisa Murkowski, R-Alaska, told McConnell in the letter that a Feb. 10 draft version of the Republican's repeal and replacement plan...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.